You will be redirected to the website of our parent company, Schönherr Rechtsanwälte GmbH: www.schoenherr.eu
"Schoenherr continues to attract a variety of high-level transactional instructions."
Our core practice is advising and representing clients on transactions and complex corporate and commercial matters. Over the years, the practice group has built an outstanding record on headline and key transactions in Austria and throughout CEE/SEE.
Schoenherr’s m&a teams advise on national and cross-border transactions, including private m&a, public tender offers, transactions for listed companies, private equity and venture capital transactions, auction sales, privatisations, strategic alliances and joint ventures. Dedicated teams within the practice group focus on restructuring and insolvency, working together with the firm’s insolvency specialists to advise on distressed companies m&a.
Together with the firm’s regulatory specialists, the corporate/m&a group has developed industry-specific expertise covering inter alia the following sectors: energy, financial institutions, telecoms, automotive, media and pharmaceuticals.
Schoenherr’s corporate/m&a practice has consistently been ranked in the highest tier by acclaimed legal directories such as Chambers Global and Chambers Europe, IFLR1000, Legal 500 and JUVE. Among other rankings Schoenherr has been repeatedly ranked number 1 in Austria by MergerMarket rankings.
our team
Our international team advises on merger and acquisition matters across the CEE region.
top rankings
We are ranked in Tier 1 in Legal500 and Chambers as well as Germany's leading legal directory, JUVE magazine.
07 August 2026
slovenia croatia hungary poland
B.Brežan J.Primožič M.Črnilec T.Žagar K.Kreča M.Gajšek G.Tanko B.Malijanski Š.Lovšin A.Kalacanović V.Mandarić* L.Saraf* S.Sušanj* K.Hetényi A.Menczelesz V.Hiesz K.Solarz-Włodarska S.Czerwiński P.Baran K.Jurzak M.Kowalski A.Nowacka
CEE: Schoenherr advises Lauxera Capital Partners on acquisition of GenePlanet stake
Schoenherr, acting as Slovenian, Croatian, Hungarian and Polish counsel alongside McDermott Will & Schulte, advised Lauxera Capital Partners on its acquisition of an approximately 25 % stake, representing approximately 31 % of the voting rights, in genEplanet, osebna genetika, d.o.o. ("GenePlanet") from several shareholders. The strategic investment supports GenePlanet's global expansion in diagnostics.
see all m&a news here